GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HNF4A | hg38_v1_chr20_+_44401269_44401301 | 0.59 | 8.4e-22 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_42811884 Show fit | 26.99 |
ENST00000514985.6
ENST00000511224.5 ENST00000507920.5 ENST00000510965.1 |
selenoprotein P |
|
chr6_+_31982057 Show fit | 23.68 |
ENST00000428956.7
ENST00000498271.1 |
complement C4A (Rodgers blood group) |
|
chr6_+_32014795 Show fit | 23.22 |
ENST00000435363.7
ENST00000425700.3 |
complement C4B (Chido blood group) |
|
chr9_-_101442403 Show fit | 20.66 |
ENST00000648758.1
|
aldolase, fructose-bisphosphate B |
|
chr1_-_15585015 Show fit | 20.64 |
ENST00000375826.4
|
agmatinase |
|
chr16_+_8674605 Show fit | 17.83 |
ENST00000268251.13
|
4-aminobutyrate aminotransferase |
|
chr20_+_57561103 Show fit | 17.10 |
ENST00000319441.6
|
phosphoenolpyruvate carboxykinase 1 |
|
chr17_+_43780425 Show fit | 16.53 |
ENST00000449302.8
|
CFAP97 domain containing 1 |
|
chr6_+_31946086 Show fit | 13.35 |
ENST00000425368.7
|
complement factor B |
|
chr9_+_136945234 Show fit | 12.45 |
ENST00000371634.7
|
complement C8 gamma chain |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 46.9 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
4.5 | 31.8 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
3.4 | 27.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
3.8 | 26.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.3 | 25.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
3.4 | 23.6 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
3.4 | 20.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
4.1 | 20.6 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
0.6 | 20.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
4.7 | 18.8 | GO:0006562 | proline catabolic process(GO:0006562) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 62.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 42.7 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 42.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 33.3 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 30.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
1.3 | 27.0 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.3 | 21.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.5 | 20.7 | GO:0034451 | centriolar satellite(GO:0034451) |
2.6 | 18.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 18.1 | GO:0005796 | Golgi lumen(GO:0005796) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 49.0 | GO:0001848 | complement binding(GO:0001848) |
1.9 | 30.2 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
2.2 | 27.0 | GO:0008430 | selenium binding(GO:0008430) |
4.5 | 26.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
3.4 | 23.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.8 | 23.7 | GO:0071949 | FAD binding(GO:0071949) |
6.9 | 20.7 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
1.4 | 20.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
4.6 | 18.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
4.5 | 17.8 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 62.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 26.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 20.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 18.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 16.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 13.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.6 | 13.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 12.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 11.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 11.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 50.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.0 | 38.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 37.4 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
1.4 | 31.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 25.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 24.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 22.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.0 | 20.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 17.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.1 | 17.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |